Hot showers release volatile compounds (chloroform and other disinfection byproducts, radon where present) that you breathe in; for radon, inhalation is most of the risk, and only whole-house treatment helps. Skin absorbs almost no lead, arsenic or PFAS. Shower filters are certified only for chlorine (NSF/ANSI 177); no independent test of their effect on volatile byproducts was found. A trial of water softeners found no benefit for existing eczema.
| Source | What it found (quoted) and its limits | Evidence |
|---|---|---|
| Thomas KS et al. A randomised controlled trial of ion-exchange water softeners for the treatment of eczema in children (SWET). PLoS Medicine 8(2):e1000395 (2011) · new multicentre observer-blind RCT · n = 336 children aged 6 months-16 years, 12 weeks |
Trial found "no objective difference in outcomes between the children whose homes were fitted with water softeners and those without"; both groups improved equally Route: dermal (hard water). What reduces it: Water softener does not treat established childhood eczema Limits: Treatment (not prevention) trial; UK hard-water areas |
Evidence: strong Free to read · source · added 2026-10-30 |
| Health Canada. Guideline Technical Document — Arsenic (section on dermal absorption, citing NRC 1999 and ATSDR 2000) (2006) · new agency review · n = n/a |
"Both organic and inorganic arsenic are not well absorbed by the skin." "Dermal exposure is reported to be of minor importance compared with ingestion." Route: dermal. What reduces it: Treat drinking/cooking water (RO, adsorptive media); bathing not the driver Limits: Canadian document; numeric Wester 1993 % not on page |
Evidence: strong Free to read · source · added 2026-10-30 |
| ATSDR ToxGuide for Fluorides, Hydrogen Fluoride, and Fluorine (toxguide-11) (2003 (archived 2013)) · new agency toxicological summary · n = n/a |
"Dermal – Minor route of exposure." "Oral – The predominant route of exposure for general population." "Soluble fluoride compounds are well absorbed (80–100%) through the gastrointestinal tract." Route: dermal/ingestion. What reduces it: Drinking-water treatment (RO, activated alumina) if desired; no bath treatment basis Limits: Dermal line refers to fluorides generally; no bathing-specific data |
Evidence: strong Free to read · source · added 2026-10-30 |
| National Research Council. Risk Assessment of Radon in Drinking Water. National Academies Press (1999) · new expert committee risk assessment · n = US population model |
"radon at a given concentration in water adds only about 1/10,000 as much to the air concentration"; "the inhalation pathway accounts for about 89% of the estimated cancer risk"; committee "estimates 160 lung cancer deaths in 1998" from radon released from household water; ~23 ingestion cancer deaths/yr (range 5-50) Route: inhalation (water-to-air) vs ingestion. What reduces it: Aeration or GAC at point of entry (whole-house) because release happens at every hot-water use, not just the kitchen tap Limits: Modeled; mainly private-well/groundwater issue |
Evidence: strong Free to read · source · added 2026-10-30 |
| US EPA. Basic Information about Lead in Drinking Water (web page) (current) · new agency guidance · n = n/a |
"Bathing and showering should be safe for you and your children, even if the water contains lead over EPA's action level." "Human skin does not absorb lead in water." Route: dermal. What reduces it: No shower/bath treatment needed for lead; treat drinking/cooking water Limits: Caveat on page: highly corrosive water "may require additional recommendations" |
Evidence: strong Free to read · source · added 2026-10-30 |
| Yeh A, Prueitt RL, Kerper LE, Beck BD. Evaluating dermal absorption of perfluorooctanoic acid (PFOA) and implications for other PFAS. Regul Toxicol Pharmacol (2025) · new literature review + exposure model · n = review |
Recommended provisional "1.6% fractional absorption" (finite dose); Kp 0.000044 cm/h; "Our results indicate low dermal absorption of PFOA relative to ingestion." Route: dermal. What reduces it: Point-of-use RO/GAC for drinking; whole-house not needed for dermal Limits: Authors at consulting firm (Gradient); PFOA proxy for other PFAS |
Evidence: moderate Access unknown · source · added 2026-10-30 |
| Jabbar-Lopez ZK et al. Randomized controlled pilot trial with ion-exchange water softeners to prevent eczema (SOFTER trial). Clin Exp Allergy 52(3):405-415 (2022) · new pilot RCT (feasibility) · n = 78 infants randomized (39/arm), hard-water London homes |
Visible eczema at 6 months 33% (12/36) softener vs 48% (15/31) control, difference −15% (95% CI −38 to 8.3%); no statistical testing (pilot) Route: dermal (hard water). What reduces it: Softener installed before birth — signal only; definitive trial needed Limits: Pilot, underpowered, 15% attrition |
Evidence: moderate Free to read · source · added 2026-10-30 |
| Nuckols JR, Ashley DL, Lyu C, Gordon SM, Hinckley AF, Singer P. Influence of tap water quality and household water use activities on indoor air and internal dose levels of trihalomethanes. Environ Health Perspect 113(7):863-870 (2005) · new controlled household-activity study, blood and breath · n = 7 participants, 2 sites (NC high-THM, TX low-THM) |
"All hot water use activities yielded a 2-fold increase in blood or breath THM concentrations for at least one individual"; showering blood THM up ~5-15-fold (NC) and ~5-fold (TX); "Ingesting a cold tap water beverage was the only activity that did not meet the study's 2-fold inclusion threshold" Route: inhalation+dermal (shower, bath, dishwashing) vs ingestion. What reduces it: Lower source-water THMs; shorter hot-water activities Limits: n=7; authors state more research needed on public-health implications |
Evidence: moderate Free to read · source · added 2026-10-30 |
| NSF/ANSI 177 Shower Filtration Systems — Aesthetic Effects (described in PM Engineer trade article) (2004 (standard)) · new certification standard description · n = n/a |
Certifies free available chlorine only: ≥50% reduction of a 2.0 mg/L challenge at 104 ±4°F (40 ±2°C), ≥1 gpm, 15-min on/off cycling; system "has not been evaluated for free available chlorine reduction performance in the presence of chloramines"; "any issues with potential health effects of chlorine exposure are not covered in this certification" Route: inhalation+dermal. What reduces it: Buy NSF/ANSI 177-certified unit if chlorine is the goal; no standard certifies THM/VOC removal in showers Limits: Trade-press description; standard text itself paywalled |
Evidence: moderate Free to read · source · added 2026-10-30 |
| Backer LC, Ashley DL, Bonin MA, Cardinali FL, Kieszak SM, Wooten JV. Household exposures to drinking water disinfection by-products: whole blood trihalomethane levels. J Expo Anal Environ Epidemiol 10(4):321-326 (2000) · new controlled human exposure, blood biomonitoring · n = 31 adults (shower n=11, bath n=10, drink 1 L n=10) |
Highest blood THM levels "in the 10-minute shower group and the lowest in the drinking group"; "household activities such as bathing and showering are important routes for human exposure to THMs" Route: inhalation+dermal vs ingestion. What reduces it: Lower water THM; shorter/cooler showers (see Backer 2008, EHP 116:57, n=100, which judged the 2000 clustering "likely a spurious effect attributed to a small (n = 10) sample size") Limits: Small groups; Backer 2008 later judged part of the 2000 pattern "likely a spurious effect attributed to a small (n = 10) sample size" |
Evidence: moderate Paywalled · source · added 2026-10-30 |
| Kuo H-W, Chiang T-F, Lo I-I, Lai J-S, Chan C-C, Wang J-D. Estimates of cancer risk from chloroform exposure during showering in Taiwan. Sci Total Environ 218:1-7 (1998) · new exposure model with measured shower-water chloroform · n = Taiwan tap-water samples (n not in abstract) |
"A 10-min shower would result in chloroform exposure with a 3:4:3 ratio ingestion, inhalation, skin absorption"; "changes to 1:7:2 for a 20-min shower" (Table 3: 10-min shower = ingestion 30%, inhalation 43%, skin 27%) Route: inhalation+dermal+ingestion. What reduces it: Shorter showers (share from inhalation rises steeply with duration) Limits: Model (Little 1992/Beavers 1996 parameters), not biomonitoring; Taiwan water |
Evidence: moderate Free to read · source · added 2026-10-30 |
| Gordon SM, Wallace LA, Callahan PJ, Kenny DV, Brinkman MC. Effect of water temperature on dermal exposure to chloroform. Environ Health Perspect 106(6):337-345 (1998) · new controlled human bath exposure, breath (face mask excluded inhalation) · n = small volunteer study (n not extracted) |
Subjects at the highest water temperatures exhaled "about 30 times more chloroform" than at the lowest; at 40 °C skin flux approaches steady state in ~6-9 min Route: dermal. What reduces it: Cooler and shorter baths/showers sharply cut dermal uptake Limits: Small n; chloroform only |
Evidence: moderate Free to read · source · added 2026-10-30 |
| Weisel CP, Jo WK. Ingestion, inhalation, and dermal exposures to chloroform and trichloroethene from tap water. Environ Health Perspect 104(1):48-51 (1996) · new experimental human exposure (breath) · n = not stated in abstract |
"the ingestion dose was completely metabolized before entering the bloodstream" whereas the dose from inhalation/dermal routes "was dispersed throughout the body"; biologically effective dose depends on route and target organ Route: inhalation+dermal+ingestion. What reduces it: Reduce shower duration/temperature; ventilation Limits: Abstract-only; breath values not retrievable; first-pass metabolism argument is route-specific to chloroform |
Evidence: moderate Free to read · source · added 2026-10-30 |
| Jo WK, Weisel CP, Lioy PJ. Chloroform exposure and the health risk associated with multiple uses of chlorinated tap water. Risk Analysis 10(4):581-585 (1990) · new experimental human exposure (breath sampling) + risk model · n = not stated in abstract |
"Breath chloroform after showering was 6.0-21 μg/m³" vs pre-shower background "below 0.86 μg/m³"; combined inhalation+dermal dose from one 10-min shower "comparable to the dose estimated from daily water ingestion"; modeled risk single 10-min shower 1.22 × 10⁻⁴ vs ingestion 0.130 × 10⁻⁴ (0.15 L/day) to 1.80 × 10⁻⁴ (2.0 L/day) Route: inhalation+dermal. What reduces it: Shorter/cooler showers; bathroom ventilation; removing THM precursors/chlorine before the shower (not tested in study) Limits: 1990 US water; small study; abstract-only; model inputs not visible |
Evidence: moderate Paywalled · source · added 2026-10-30 |
| Wisconsin Dept of Health Services. Radon in Water (web page) (n.d.) · new state health agency guidance · n = n/a |
"For every 10,000 pCi/L in a household water supply, a time average of about 1 pCi/L of radon is added to the air"; "The majority (90%) of the risk from radon in water is from inhaling the radon"; single-home removal devices cost "$3,000 to $5,000 over 10 years" Route: inhalation. What reduces it: Whole-house aeration/GAC; test well water first Limits: State summary, not primary study |
Evidence: moderate Free to read · source · added 2026-10-30 |
| Minnesota Dept of Health. Reducing Exposures: Perfluoroalkyl Substances (fact sheet) (current) · new state health agency guidance · n = n/a |
"PFAS are poorly absorbed through skin"; water above guidance "is safe for bathing, showering, swimming, washing clothes, and cleaning"; "exposure from breathing while swimming or bathing is not a health concern" Route: dermal+inhalation. What reduces it: Point-of-use filter for drinking/cooking Limits: Agency statement; no primary data on page |
Evidence: moderate Free to read · source · added 2026-10-30 |
| KDF Fluid Treatment R&D Laboratory. Shower Filter Chlorine Test (Omica Organics), NSF/ANSI 177-2014 protocol (2016) · new manufacturer-commissioned lab test · n = 1 product |
Free chlorine reduction 99% at 1,000 gal, 98% at 2,000, 95% at 3,000, 91% at 7,000, 90% at 10,000 gal; flow 2.44-2.51 gpm; water temperature not stated Route: inhalation+dermal. What reduces it: Shows a KDF-type unit can hold chlorine reduction over rated life for free chlorine Limits: Confidential vendor report; media maker tested own media; no chloramine, THM or VOC data; no independent replication found |
Evidence: weak Free to read · source · added 2026-10-30 |
Evidence grade: strong = trials, large field studies or official datasets; moderate = smaller or lab studies with real water; weak = single small studies, makers' specs or secondary reports. "Free to read" means the source itself is free to read online.